Direct health and residential care costs of people living with dementia in Australian residential aged care by Gnanamanickam, Emmanuel S. et al.
Received: 30 June 2017 Accepted: 27 November 2017DOI: 10.1002/gps.4842R E S E A R CH AR T I C L EDirect health and residential care costs of people living with
dementia in Australian residential aged care
Emmanuel S. Gnanamanickam1,2 | Suzanne M. Dyer1,2 | Rachel Milte1,2,3 |
Stephanie L. Harrison1,2 | Enwu Liu1,2,4 | Tiffany Easton1,2 | Clare Bradley1,2,5 |
Rebecca Bilton1,2 | Wendy Shulver1,2 | Julie Ratcliffe2,3 | Craig Whitehead1,2 |
Maria Crotty1,21Department of Rehabilitation, Aged and
Extended Care, Flinders University, Bedford
Park, SA, Australia
2NHMRC Cognitive Decline Partnership
Centre, The University of Sydney, Sydney,
NSW, Australia
3 Institute for Choice, University of South
Australia, Adelaide, SA, Australia
4Mary MacKillop Institute for Health
Research, Australian Catholic University,
Melbourne, VIC, Australia
5 Infection and Immunity‐Aboriginal Health,
SAHMRI, Adelaide, SA, Australia
Correspondence
Dr Emmanuel Gnanamanickam, Department of
Rehabilitation, Aged and Extended Care,
Flinders University, Level 4, Rehabilitation
building, Flinders Medical Centre, Bedford
Park, SA 5042, Australia.
Email: emmanuel.gnanamanickam@sa.gov.au
Funding information
National Health and Medical Research Council
(NHMRC) Partnership Centre on Dealing with
Cognitive and Related Functional Decline in
Older People (CDPC), Grant/Award Number:
GNT9100000- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
This is an open access article under the terms of
medium, provided the original work is properly cite
© 2018 The Authors. International Journal of Geri
[Correction added on 19 March 2018, after first on
replaced to represent the data in Table 4 and in
some numbers were corrected. See online supplem
Int J Geriatr Psychiatry. 2018;33:859–866.Objectives: This analysis estimates the whole‐of‐system direct costs for people living with
dementia in residential care by using a broad health and social care provision perspective and
compares it to people without dementia living in residential care.
Methods: Data were collected from 541 individuals living permanently in 17 care facilities
across Australia. The annual cost of health and residential care was determined by using individual
resource use data and reported by the dementia status of the individuals.
Results: The average annual whole‐of‐system cost for people living with dementia in
residential care was approximately AU$88 000 (US$ 67 100) per person in 2016. The cost of
residential care constituted 93% of the total costs. The direct health care costs were comprised
mainly of hospital admissions (48%), pharmaceuticals (31%) and out‐of‐hospital attendances
(15%). While total costs were not significantly different between those with and without demen-
tia, the cost of residential care was significantly higher and the cost of health care was signifi-
cantly lower for people living with dementia.
Conclusion: This study provides the first estimate of the whole‐of‐system costs of providing
health and residential care for people living with dementia in residential aged care in Australia
using individual level health and social care data. This predominantly bottom‐up cost estimate
indicates the high cost associated with caring for people with dementia living permanently in
residential care, which is underestimated when limited cost perspectives or top‐down, population
costing approaches are taken.
KEYWORDS
Australia, cost, dementia, health care utilisation, residential aged care1 | INTRODUCTION
The worldwide prevalence of dementia in 2010 was estimated to be
35.6 million and is projected to increase to 115.4 million by 2050.1 This
is accompanied by an increasing demand for residential aged care- - - - - - - - - - - - - - - - - - - - - - - - - - -
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of 1.4% of gross domestic product was spent on public funding of
long‐term care in OECD countries and is estimated to double by
2050.2
In Australia, over half of the permanent residents living in
residential aged care are likely to have dementia.3 People with demen-
tia are also likely to have increased health care needs, comorbidities,
and hospitalisations.4-7- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Key points
• The annual health and residential care costs for people
with dementia in residential care is AU$88 000 per
person in 2016.
• 93% of the costs are attributable to residential care.
• Health care costs were lower and residential care costs
higher for people with dementia compared to those
without.
• The health and residential care costs are substantial and
high compared to previous estimates using limited cost
perspectives or top‐down approaches.
860 GNANAMANICKAM ET AL.Within the context of an ageing population, it is critical to
ascertain the cost of providing long‐term care for people with
dementia. Several studies have estimated this with large variations in
the costing approach, perspective, setting, and location.8,9 Most
commonly, studies use a predominantly macro or top‐down approach
or use a mixture of macrocosting and microcosting (bottom‐up)
approaches.10-14 Top‐down approaches provide an overarching view
but with lower precision,15 and it is generally only feasible to
determine resource use and costs for those with a formal diagnosis
of dementia. However, dementia in a residential care setting often
remains undiagnosed—approximately half or more of dementia cases
in residential care are undetected.16,17 In addition, various costing
estimates use different perspectives and are conducted in community
or mixed settings. A recent Alzheimer's Australia report used a cost of
illness approach and estimated costs directly attributable to demen-
tia.14 In recent reviews of the cost of dementia,8,9 the majority of
studies used a societal perspective but only 6 were conducted
exclusively in residential care settings. Most existing estimates of cost
of dementia are in North American or European countries.10,14
In Australia, previous studies have estimated the costs of dementia
care by using a top‐down approach10 or from a consumer contribution
(out‐of‐pocket) perspective.14 However, the true cost of providing
residential care for people living with dementia in Australia is currently
unknown. This study using a predominantly microcosting approach
aims to provide a detailed assessment of the whole‐of‐system costs
of people living with dementia in residential aged care from a health
and residential care provision perspective. A secondary aim was to
compare the costs for people with and without dementia in this
setting.2 | METHODS
2.1 | Participants
This analysis is part of the INSPIRED (Investigating Services Provided
in the Residential Care Environment for Dementia) study that aimed
to determine and compare quality of life, quality of care and utilisation
of health care resources, and costs of individuals living in residential
care facilities that provide alternative models of care for people with
cognitive impairment and dementia. The study enrolled 541 partici-
pants, residing for 12 months or longer in 17 facilities managed by 5
not‐for‐profit care providers across 4 Australian states (7 facilities in
South Australia, 5 in New South Wales, 3 in Western Australia, and 2
in Queensland). Facilities known to be dementia specific or having a
high proportion of residents with dementia were intentionally
approached for recruitment. Although approached, no for‐profit pro-
viders agreed to participate. Individuals in palliative care and those
who had complex medical issues that would impede participation were
excluded. Data on demographic and social characteristics, health and
function, care provision, quality of care and quality of life were col-
lected from participants and/or carers (for participants with significant
cognitive impairment), and formal care staff at a single time point
between January 2015 and February 2016. Retrospective health care
utilisation data were sourced from Commonwealth and state datacustodians for the 12 months prior to participant data collection.
Human research ethics approval was obtained from the Flinders Uni-
versity Social and Behavioural ethics committee and all relevant custo-
dians of health care data.2.2 | Dementia status
Dementia was defined as either a diagnosis of dementia from medi-
cal records or cognitive impairment based on the Psychogeriatric
Assessment Scales‐Cognitive Impairment Scale (PAS‐Cog with a
score of ≥5). The PAS‐Cog is routinely used for Australian govern-
ment assessments in residential care. It measures cognitive impair-
ment on a scale from 0 to 21 with higher scores indicating severe
cognitive impairment.18 Almost 20% (N = 103) of study participants
had a PAS‐Cog score, indicative of probable dementia but no diagno-
sis recorded.2.3 | Resource use and cost data
A broad health and residential care provision perspective was used for
the costs. This perspective included the majority of the all‐cause cost
to the government and to individuals living with dementia but did
not include private health insurance costs. All costs were reported in
Australian dollars (AU$) after adjusting to 2016 prices by applying
the health sector specific price deflator.19 Costing methods followed
standard Australian guidelines.20 Additional out‐of‐pocket costs were
incorporated as detailed below. Key cost estimates were converted
to 2016 US$ (AU$1 = US$0.7617).21
2.3.1 | Residential care costs
The user fee component of residential care costs was determined as
85% of the Australian single person age pension that is charged to all
users of residential care in Australia. Government funding was
determined based on the levels of funding received by the care
providers based on the Aged Care Funding Instrument (ACFI). The
ACFI provides funding based on core individual care needs in the
domains of daily living, behaviour, and complex health care.22 For this
analysis, the basic subsidy rates for the period ending June 2016 were
applied to the levels of care need across the 3 domains to calculate
GNANAMANICKAM ET AL. 861government funding of residential care costs. The user paid fees and
ACFI‐based subsidy together are recommended for calculating
residential care costs in Australia20 and comprise 85% of the revenue
received by residential care facilities.23
2.3.2 | Health care utilisation and costs
Health care utilisation included out‐of‐hospital service use, hospital
admissions and emergency service use, and pharmaceutical use. The
utilisation measures for each of these along with their source and cost-
ing methodology are presented in Table 1. Linked Medicare Benefits
Schedule (MBS) and Pharmaceutical Benefits Scheme (PBS) data were
not complete; 16% did not provide valid consent (ie, proxy consent not
accepted as valid consent by data custodian) to obtain this data. How-
ever, a sensitivity analysis (not tabulated) of out‐of‐hospital medical
services using data from only those who provided full consent did
not alter the estimates across these health care components or total
costs. The impact on pharmaceutical use data was negligible as the pri-
mary data source for pharmaceutical use was pharmacy records
(Table 1). Hence, no imputation was made and complete case analysis
was conducted.2.4 | Analysis
Demographic, social, health, and facility characteristics were compared
by dementia status and P‐values calculated by using t‐tests or chi‐
squared tests as appropriate. Proportions of participants who accessed
services, the mean number of services accessed, and the mean annual
costs were reported by dementia status, and differences were
compared using t‐tests. Statistical significance was considered at P‐
value < 0.05. The proportion of mean costs for each cost component
were displayed graphically. The influence of outliers of costs were
examined; only 1 outlier was found in hospital admissions costs andTABLE 1 Health care utilisation measures and costing methodology
Health Care
Utilisation
Components Categories/definitions Source of D
Out‐of‐hospital services Medical attendances, diagnostic,
imaging, and investigation

















Abbreviations: DPMQ, Dispensed Price for Maximum Quantity; MBS, Medicare
aThe MBS is a listing of all medical services provided under the Medicare progr
bAustralian Consortium for Classification Development.25
cIndependent Hospital Pricing Authority.26
dThe DPMQ incorporates cost of drugs, dispensing costs and out of pocket con
eDepartment of Health.27was assessed to be a genuine outlier based on a review of the service
use items. Excluding this outlier did not change the statistically
significant difference in health care costs between participants with
and without dementia. Medians were also compared using the
Wilcoxon‐Mann‐Whitney test to exclude the effect of outliers.3 | RESULTS
A total of 1323 individuals were assessed for eligibility, 901 were
eligible and 541 consented to participate in the study. Four of the 17
participating facilities were located outside of major cities, and the
mean facility size was 83 beds. Fourteen facilities reported having a
dementia‐specific unit or wing. Overall, 84% of the participants had
dementia based either on medical diagnosis or cognitive assessment
score, mean age was 85 years, approximately 75% were female, and
they had on average 3.6 comorbidities in addition to dementia
(Table 2). People with dementia had significantly worse activities of
daily living (Modified Barthel index), neuropsychiatric symptom scores
and fewer weekly social interactions than those without dementia. A
smaller proportion of people with dementia lived in a large facility
and more were married.
Overall, the characteristics of the INSPIRED study sample were
similar to the broader Australian national population living perma-
nently in residential aged care in terms of age, marital status, and
ACFI‐based care needs. However, there were more female, more
people living in facilities in major cities, and a higher proportion living
in medium and large sized facilities (Table S1 in the Supporting
Information).
The majority of participants with dementia had high level of care
need across all 3 ACFI domains (56‐76%; Table 3). A greater proportion
of those with dementia had high levels of need for activities of dailyata, Measure Calculation
alth Medicare Benefits
(MBS)a, number of services
Provider charged fees for each item code
applied as per the Medicare Benefits
Schedule (MBS)a
dians of hospital data, number
ions
Admissions grouped into Australian
Refined Diagnosis Related Groups (AR‐
DRGs)b and Round 18 (2013‐2014)c
cost weights applied
dians of emergency
nt data, number of
tions
Presentations grouped into Urgency
Related Groups (URGs) and Round 18
(2013‐2014)c cost weights applied
harmacies of respective
(supplemented by data from
n charts and PBS), number of
edications
Dispensed Price for Maximum Quantity
(DPMQ)d from the Pharmaceutical
Benefits Scheme (PBS)e applied by PBS
item codes
Benefits Schedule; PBS, Pharmaceutical Benefits Scheme.
amme of the Australian government.24
tributions.
TABLE 2 Characteristics of the INSPIRED study participants by dementia status
Characteristic Dementiaa (n = 453) No Dementia (n = 88) P‐value
Age, mean (SD) 85.4 (8.6) 85.8 (8.3) 0.693
Female, n (%) 339 (74.8) 64 (72.7) 0.678
Currently married, n (%) 125 (27.7) 12 (13.6) 0.006
Barthel index, mean (SD) 35.8 (31.6) 63.8 (29.2) <0.001
Number of comorbidities, mean (SD) 3.6 (1.4) 3.9 (1.4) 0.05
Neuropsychiatric inventory, mean (SD) 9.0 (6.5) 4.4 (4.0) <0.001
Resided in a large facility, n (%) 230 (50.8) 58 (65.9) 0.009
Resided in a regional location, n (%) 104 (23.0) 17 (19.3) 0.453
Weekly social interaction with family and friends, n (%) 308 (68.9) 70 (80.5) 0.030
aA diagnosis of dementia or PAS‐Cog ≥ 5.
TABLE 3 Care needs of INSPIRED study participants (n = 538) as
assessed by the ACFI domains by dementia status
ACFI Domains Levels Dementia n (%) No Dementia n (%)
Activities of daily living Nil 0 (0) 0 (0)
Low 37 (8) 23 (26)
Medium 138 (31) 29 (33)
High 275 (61) 36 (41)
Behaviour Nil 5 (1) 13 (15)
Low 21 (5) 23 (26)
Medium 83 (18) 21 (24)
High 341 (76) 31 (35)
Complex health care Nil 9 (2) 2 (2)
Low 56 (12) 12 (14)
Medium 134 (30) 21 (24)
High 251 (56) 53 (60)
862 GNANAMANICKAM ET AL.living and behaviour compared to those without dementia. The 2
groups were similar in the complex health care domain. The levels of
need translated to an overall annual basic cost of providing residential
care of approximately $82 300 (US$62 700) for those with dementia
and $73 200 (US$55 700) for those without dementia (Table 4), a sta-
tistically significant difference of about AU$9100 (US$7000) annually
per person.
Across all health care components, a lower proportion of partici-
pants with dementia accessed services in comparison to those without
dementia (Table 4). The mean number of services accessed was also
significantly lower for participants with dementia for all health care
components except other attendances (nursing, optometry, etc.) and
emergency presentations. Accordingly, total health care costs and
costs of all individual health care components except emergency pre-
sentations were significantly lower for participants with dementia.
Median total health care costs were also significantly lower for those
with dementia in comparison to those without (dementia: $2947, no
dementia: $5556, P < .0001).
Despite the higher residential care costs for people with dementia,
lower health care utilisation meant that there was no significant
difference in total resource use (residential care plus health care) costs
by dementia status. The mean annual whole‐of‐system cost for those
with dementia was about $88 000 (US$67 100; Table 4 and Table S2
in the Supporting Information).
The single largest component of total costs was for provision of
residential care in both groups, representing 93% of all costs for people
with dementia (Figure 1). Hospital admission costs accounted for thelargest proportion of health care costs: 48% for those with dementia
and 53% for those without dementia. Pharmaceuticals and general
practitioner attendances costs accounted for 31% and 14% of health
care costs, respectively, for participants with dementia. Other compo-
nents of health care represented a relatively low proportion of health
care costs (<10%) (See online supplement for further explanation of
results).4 | DISCUSSION
In this Australian study of individuals in long‐term residential aged
care, the annual whole‐of‐system costs of those living with dementia
was approximately AU$ 88 000 (US$ 67 100) per person from a broad
health and residential care provision perspective. This estimate was
derived by using individual level resource use data including both gov-
ernment and out of pocket costs of residential care plus
out‐of‐hospital and in‐hospital all‐cause health care utilisation. This
analysis provides, for the first time, a comprehensive estimate of the
direct costs of providing health and residential care for this population
in Australia using a predominantly bottom‐up approach.
The direct costs for a person living with dementia in a care setting
in Australia have recently been estimated as $55 904 for the first year
after diagnosis and $23 810 for subsequent years.14 These modelled
estimates only included health care costs that were directly
attributable to dementia and residential care costs from an out of
pocket cost perspective.
Our costing, in contrast, provides an estimate capturing costs to
both government and individuals, based on individual all‐cause
resource use of people with dementia living long‐term in residential
care. In the absence of a cost estimate from a societal perspective,
such a comprehensive estimate is important for planning for both
providers and policy makers and quantifies the financial impact of
dementia in this population.
Previous estimates of direct costs of dementia for people living
in institutionalised settings from a societal perspective, across a
range of countries, range between AU$15 000 and 73 000 (in
2013 prices), with an average of $41 000.8,14 While it is clear that
some estimates are only for costs directly attributable to dementia,
this is unclear for other estimates. In another review that reported
all‐cause costs separately, the total costs of dementia for people
TABLE 4 Annual resource use and costs per person (2016 Australian dollars) by dementia status
Cost components
% (n) Accessed
Services Mean (95%CI) Number of Services Mean (95% CI) Annual Cost in AU$
Dementia
No
Dementia Dementia No Dementia Dementia No Dementia
Residential care costs ‐ ‐ ‐ ‐ 82 316a (81 087, 83 546)*** 73 166 (69 796, 76 537)
Total out of hospital ‐ ‐ ‐ ‐ 2874 (2691, 3057)*** 4873 (4200, 5545)
General practitioner
attendances
73 (327)* 84 (74) 13.5 (12.3, 14.7)*** 20.6 (16.9, 24.2) 806 (732, 880)*** 1292 (1076, 1508)
Specialist attendances 17 (78)*** 51 (45) 0.4 (0.3, 0.5)*** 2.0 (1.1, 2.9) 51 (34, 67)** 236 (105, 367)
Other attendances 24 (106)*** 55 (48) 0.8 (0.5, 1.1) 2.0 (0.8, 3.2) 26 (18, 34)** 69 (42, 97)
Total attendances 73 (330)** 86 (76) 14.7 (13.4, 16.0)*** 24.6 (20.4, 28.7) 883 (800, 964)*** 1597 (1307, 1887)
Diagnostic and
investigations
5 (23)*** 28 (25) 0.1 (0.0, 0.1)*** 0.4 (0.2, 0.6) 5 (3, 7)** 39 (18, 59)
Diagnostic imaging
services
15 (66)*** 40 (35) 0.3 (0.2, 0.4)*** 0.9 (0.6, 1.3) 28 (20, 36)** 105 (58, 151)
Pathology services 62 (277)*** 83 (73) 7.3 (6.2, 8.4)*** 14.9 (11.4, 18.3) 116 (100, 132)*** 232 (189, 276)
Therapeutic
procedures
9 (39)*** 30 (26) 0.3 (0.1, 0.4)** 1.3 (0.6, 2.1) 21 (9, 33)* 207 (50, 364)
Total medical services 75 (339)** 91 (80) 22.6 (20.4, 24.8)*** 42.1 (35.2, 49.0) 1053 (954, 1151)*** 2180 (1748, 2612)
Pharmaceuticals (no.
unique medications)
98 (443) 99 (87) 13.7 (13.1, 14.2)*** 17.5 (15.7, 19.3) 1821 (1687, 1955)*** 2693 (2303, 3083)
Hospital admissions 22 (97)*** 40 (35) 0.4 (0.3, 0.5)* 1.2 (0.5, 2.0) 2819 (1961, 3677)* 5585 (3045, 8126)
Emergency department 14 (59) 18 (20) 0.2 (0.1, 0.3) 0.2 (0.1, 0.3) 139 (97, 181) 166 (61, 272)
Total health care utilisation
costs
‐ ‐ ‐ ‐ 5832b (4911, 6753)** 10 624 (7728, 13 520)
Total resource use costs ‐ ‐ 88 148c (86 587, 89 710) 83 790 (79 131, 88 450)







GNANAMANICKAM ET AL. 863living in residential care including informal care costs ranged from US
$22 000 up to US$48 000 in 2006.9 Our costing of approximately
AU$88 000 (US$ 67 100) per person in 2016 shows that the cost
of care for people with dementia is substantial and potentially higher
than previously estimated. True costs would be even higher if infor-
mal care and other indirect and intangible costs are taken into
consideration.
In our estimate of whole‐of‐system costs, the highest proportion
of costs are those incurred for the provision of residential care (93%
for people with dementia). This proportion is similar to the estimate
of 88% of direct health costs being due to residential care for all people
living with dementia in a 2002 Australian estimate10 and in a more
recent study in the UK (95%).28 It is also consistent with the range
(85‐100%) reported for people living in residential care in an
international review.8
The secondary aim of this analysis was to compare the costs
between participants with dementia and those without. Lower health
care costs for those living with dementia were driven by lower
hospital admissions, emergency presentations, medical services, and
pharmaceutical use. This has been observed previously in peoplewith dementia in long‐term care29,30 and in the last few years of
life.31 These differences may be a function of the baseline differ-
ences between the groups; comorbidities were marginally lower
and functional status was worse for those with dementia. Comorbid-
ities such as diseases of the respiratory or circulatory system or
congestive heart failure are associated with higher rates of
hospitalisation in residents of care facilities32; thus, the higher rates
of comorbidities in those without dementia in our study may partly
explain the higher rate of hospital admissions. The differences in
our study likely reflect differences between these populations in
most residential care settings.
Hospital admissions represented a large proportion of direct
health care costs (ie, excluding costs of residential care), being 48%
for those with dementia. However, a low proportion of total admis-
sions in this study were due to ambulatory‐care sensitive conditions
(below the national performance target of 8.5%33), so it is considered
that the majority of these were unavoidable.
Some of the facilities in this study provided specialised care for
people with dementia. It has previously been suggested that in a man-
aged care environment, secondary and tertiary prevention measures
FIGURE 1 Components of resource use as proportions (mean) of all (health plus residential care) costs (top half) and healthcare costs (bottom half)
864 GNANAMANICKAM ET AL.may improve care and therefore reduce the cost of caring for those
with dementia.31 However, further exploration of the drivers for cost
differences between these groups was considered beyond the scope
of this analysis but warrants further exploration in future studies.
This study has a number of strengths. We collected comprehen-
sive data on an older population living in residential care with a high
prevalence of cognitive impairment that is largely similar to the resi-
dential aged care population in Australia (Table S1 in the Supporting
Information). All resource use data and costing were based on indi-
vidual data with linked health care utilisation. This predominately
bottom‐up costing approach provides precision and is sensitive to
differences within the population being studied. For the first time,
residential care costs were estimated by using the ACFI assessment,
so these are sensitive to the individual care needs of the population.
However, this approach is not affected by facility‐level factors such
as type of provider or size of facility. While the ACFI‐based care
costs equate the funding provided for care for these individuals, it
may not completely reflect the actual cost of care provided from
the providers' perspective. Future costing studies should also address
cost variations due to additional factors including the type and size of
both care facilities and providers. Considering the rigours of
collecting complex data in this population, this study is relatively
large with a good cross section of care facilities across urban and
rural locations across Australia.
We examined the costs of dementia as a broad perspective of
health and social service provision. The costing methodology follows
standard Australian guidelines20 and, as such, is robust in methodology.
The costing approach is generally conservative. Data on public hospital
utilisation and emergency presentations are from governmentadministrative records. Private hospital utilisation is less comprehen-
sively recorded in some jurisdictions and hence may be
underestimated. However, these administrative records are considered
to be more reliable than retrospective self‐report or records of the care
facilities, particularly in this population.34
Additionally, there is some under estimate of out‐of‐hospital
medical services and associated costs due to missing data. These
services accounted for a small proportion (<2%) of total health and
residential care costs (Figure 1). Accordingly, the differences by
dementia status for these services need to be interpreted with
caution.
The study participants were those living in residential care for
12 months or more. Hence, this costing provides a resource use and
cost estimate reflective of the costs of ongoing care and is likely to
provide a source for conservative estimates in comparison to all
residents of aged care facilities.
Limitations of the study are primarily related to the observational
nature of the study. The participating facilities were intentionally
approached based on a high prevalence of residents living with
dementia in their facilities and 82% of the facilities provided some level
of dementia‐specific care. All consenting facilities were run by
not‐for‐profit providers. Thus, generalisability of the study findings to
both facilities that do not provide dementia‐specific care and to the
for‐profit sector may be limited. However, approximately 70% of all
permanent residents in care in Australia live in a not‐for profit facil-
ity.23 Both specialised dementia care facilities and not‐for‐profit pro-
viders may provide a higher quality of care for people living with
dementia; thus, the estimate of the costs of residential and health care
utilisation within this study may be conservative.35
GNANAMANICKAM ET AL. 8655 | CONCLUSION
In a sample of Australians living permanently in residential care, the
annual cost of residential and health care for those living with
dementia is approximately AU$88 000 per person (US$ 67 100). The
costs of residential care were estimated as comprising 93% of the total
whole‐of‐system cost for this population. The direct health care costs
were driven mainly by the cost of hospital admissions (48% of health
care costs), pharmaceuticals (31%), and attendances (14%). This analy-
sis provides, for the first time, a comprehensive estimate of the cost of
providing health and residential care for this population using individ-
ual service use data and a predominantly bottom‐up costing approach.
The cost is significantly higher than that obtained with other perspec-
tives or approaches, reflecting a significant financial burden of care for
people with dementia.
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